- Cerebral Effects of Pegylated Interferon in Hepatitis C Positive SubjectsConditions: Hepatitis C
1 Location available
- Pioglitazone in Hepatitis CConditions: Chronic Hepatitis C
1 Location available
- Transplant Patient Registry of Liver, Kidney and/or PancreasConditions: Hepatitis B - Hepatitis C - Liver Cirrhosis - Hepatocellular Carcinoma - Polycystic Kidney Diseases
1 Location available
- Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASHConditions: Nonalcoholic Steatohepatitis - Liver Diseases
1 Location available
- Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis BConditions: Chronic Hepatitis B e Antigen Positive - Chronic Hepatitis B e Antigen Negative
1 Location available
- Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of CConditions: Genotype 1 Chronic Hepatitis C
23 Locations available
- Effective Treatment of Hepatitis C in Substance UsersConditions: Hepatitis C - Opiate Dependence
1 Location available
- Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV TherapyConditions: HIV - Hepatitis C - Infections
4 Locations available
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore AreaConditions: Carcinoma, Hepatocellular - Liver Cirrhosis, Alcoholic - Hepatitis, Alcoholic - Hepatitis, Chronic - Hepatitis, Viral, Human
4 Locations available
- Study of SCY-635, Pegasys and Copegus in Hepatitis CConditions: Hepatitis C Infection
3 Locations available
- A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously UntrConditions: Hepatitis C, Chronic
43 Locations available
- Observational Study of Persons With Hepatitis B Virus Infection in North AmericaConditions: Chronic Hepatitis B e Antigen Positive - Chronic Hepatitis B e Antigen Negative
1 Location available
- Efficacy and Safety Study of DEB025/Alisporivir Combined to Standard Therapy (Peg-IFN and Ribavirin) in Chronic Hepatitis C Genotype 1 naïve PatientsConditions: Hepatitis C, Chronic
11 Locations available
- Project UNITY - HIV Risk Reduction and Vaccine Education InterventionsConditions: HIV Infections - Hepatitis B
2 Locations available
- Immune Response to Hepatitis C VirusConditions: Hepatitis C - HIV Infections
1 Location available
- Polyunsaturated Fatty Acids (PUFA) in the Treatment of Non-Alcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes Mellitus (PUFA)Conditions: Fatty Liver
2 Locations available
- Risk Assessment of Long-Haul Truck DriversConditions: Gonorrhea - Chlamydia Infections - Hepatitis B - Hepatitis C - Diabetes Mellitus - Hypertension - Obesity - HIV Infections - Hyperlipidemia
1 Location available
- Characterization of Clonal B Cell Populations in HCV InfectionConditions: Hepatitis C
1 Location available
- The Role of Leptin Receptors in NASHConditions: Nonalcoholic Steatohepatitis - Metabolic Syndrome
1 Location available
- Hepatitis C Treatment and AtherosclerosisConditions: Chronic Hepatitis C - Atherosclerosis
1 Location available
- Increasing Hepatitis B Screening Among Korean Church AttendeesConditions: Hepatitis B
1 Location available
- Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C PatientsConditions: Obesity - Insulin Resistance - Metabolic Syndrome - Hepatitis C
1 Location available
- The Effect of Prolonged Fasting and Hypocaloric Diet on FGF-21 LevelsConditions: Metabolism - Fasting - Nonalcoholic Steatohepatitis
1 Location available
- Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed StConditions: Chronic Hepatitis C
9 Locations available
- Open Label Study to Evaluate the Safety, Efficacy, Viral Kinetics, Genetic, Epigenetic, and Proteomic Expression of Weekly Peginterferon Alpha 2a and Conditions: Hepatitis C - HIV
1 Location available
- A Phase 1b/2a, Open-label,Randomized, Safety, Tolerability, Dose Finding, PK/PD, and Preliminary Efficacy Study of SC Hanferon™ in Combination With RiConditions: Chronic Hepatitis C Infection - Genotype 1
5 Locations available
- A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C VConditions: Hepatitis C, Chronic
11 Locations available
- A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis CConditions: Hepatitis C, Chronic
2 Locations available
- Epidemiology, Infectivity and Natural History of Hepatitis C Virus InfectionConditions: Hepatitis C
1 Location available
- Leukapheresis for Research on HCV-Coinfected PatientsConditions: Hepatitis C - HIV Infections
4 Locations available
- FibroScan in Patients With Hepatitis B and C Presenting for Liver BiopsyConditions: Cirrhosis - Hepatitis B - Hepatitis C
3 Locations available
- Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When AdminiConditions: HIV Infections - Hepatitis B Virus
1 Location available
- A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-InfectionConditions: Hepatitis B, Chronic
8 Locations available
- S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate in Preventing Liver Cancer in Patients With Chronic Hepatitis C InfectionConditions: Infection - Liver Cancer
5 Locations available
- Psychoeducation for Hepatitis and Alcohol BehaviorsConditions: Hepatitis C - Substance Abuse
1 Location available
- Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic FibrosisConditions: Chronic Hepatitis C
9 Locations available
- Virology Follow up Study in Subjects Previously Treated With TelaprevirConditions: Hepatitis C
25 Locations available
- A Study of Vaniprevir (MK-7009) in Patients With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028 AM4)Conditions: Hepatitis C, Chronic
5 Locations available
- Study of BMS-650032 With Peginterferon Alfa-2a Plus RibavirinConditions: Hepatitis C Virus
14 Locations available
- Herpes Simplex Type 2 Co-infection in Veterans With Chronic Hepatitis CConditions: Hepatitis C Virus Infection - Infection - Herpesvirus 2, Human
1 Location available
- Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C SubjectsConditions: Hepatitis C
1 Location available
- Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic UltrasoundConditions: Normal - Alcoholism - Cirrhosis - Hepatitis C
1 Location available
- A Study of Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C VirConditions: Hepatitis C, Chronic
2 Locations available
- Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult PatientsConditions: Chronic Hepatitis B
5 Locations available
- The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic TestingConditions: Patients Undergoing Routine Health Care - Heart Diseases - Inflammatory Bowel Diseases - Autoimmune Disease - Inflammatory Diseases - Blood Coagulation Disorders - Hepatitis C - Non-Metastatic Neoplasm
1 Location available
- TMC435-TiDP16-C216 - Phase III Trial of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected PatientsConditions: Hepatitis C
10 Locations available
- Adolescents' Response to Hepatitis B Vaccine Booster DoseConditions: Hepatitis B
2 Locations available
- GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) InfectionConditions: Hepatitis C, Chronic
2 Locations available
- Ribavirin Pregnancy RegistryConditions: Birth Defects - Pregnancy Complications - Hepatitis C
1 Location available
- Hepatitis C Virus and the Humoral Immune SystemConditions: Hepatitis C Virus
1 Location available
- The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic EncephalopathyConditions: Hepatic Encephalopathy - Hepatitis C - Liver Cirrhosis
1 Location available
- Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIVConditions: Steatohepatitis
1 Location available
- Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in ChildrenConditions: Non-Alcoholic Steatohepatitis
1 Location available
- Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis CConditions: Hepatitis C, Chronic
1 Location available
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous RocConditions: Hepatitis C, Chronic
1 Location available
- Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin InhibitorsConditions: Hepatitis C Virus
1 Location available
- University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)Conditions: Nonalcoholic Steatohepatitis - Nonalcoholic Fatty Liver Disease - Type 2 Diabetes Mellitus
1 Location available
- Simvastatin for the Treatment of Chronic Hepatitis BConditions: Hepatitis B
1 Location available
- Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant PatientsConditions: Hepatitis B
1 Location available
- Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin TreatmentConditions: Hepatitis C
1 Location available
- Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV PreventionConditions: HIV Infections - Hepatitis - Sexually Transmitted Infections
2 Locations available
- Romiplostim in Treating Hepatitis C-Infected Patients With ThrombocytopeniaConditions: Hepatitis C Infection - Thrombocytopenia
1 Location available
- Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)Conditions: Steatohepatitis
32 Locations available
- Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected AdultsConditions: Hepatitis C
8 Locations available
- Immune Dysregulation in Hepatitis C Patients With or Without ArthritisConditions: Hepatitis C Patients
1 Location available
- Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-RespondersConditions: Hepatitis C Virus (HCV) Infection
46 Locations available
- Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With RibavirinConditions: Hepatitis C
13 Locations available
- A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis BConditions: HIV Coinfection - Hepatitis C - Hepatitis B - Hepatotoxicity
1 Location available
- An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUAConditions: Hepatitis C, Chronic
1 Location available
- Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV InfectionConditions: Hepatitis - HIV - Liver Cancer
4 Locations available
- A Randomized Trial of Vaccine Adherence in Young Injection Drug Users - 1Conditions: Adherence - Community Outreach - HIV Risk Behaviors - Hepatitis A Vaccines - Hepatitis B Vaccines - Hepatitis C - Needle-Exchange Programs - Substance Abuse, Intravenous
1 Location available
- Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil MonConditions: Chronic Hepatitis B
1 Location available
- A Randomized, Controlled Trial of Fluvastatin Added to Pegylated Interferon and Ribavirin (PI+R) Versus PI+R Alone for Treatment of Chronic Hepatitis Conditions: Chronic Hepatitis C
1 Location available
- Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial RespondersConditions: Hepatitis B
5 Locations available
- Genetic Analysis of Liver CancerConditions: Liver Cancer - Hepatitis B - Hepatitis C - Hepatobiliary Cancers - Hepatobiliary Cancers Liver
1 Location available
- Prediction of Hepatitis C Recurrence in Liver Transplant RecipientsConditions: Liver Transplant - Hepatitis C Virus
1 Location available
- Effect of Dietary and Life Style Modification on Post Liver Transplant ObesityConditions: Post Liver Transplantation Weight Gain - Post Liver Transplantation Obesity - Nonalcoholic Steatohepatitis
1 Location available
- Intrahepatic HCV RNA and Telaprevir Kinetics in Hepatitis C Virus (HCV)Conditions: Hepatitis C
1 Location available
- Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis CConditions: Hepatitis C - Liver Transplantation
7 Locations available
- Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus InfectionConditions: Hepatitis C, Chronic
13 Locations available
- Baclofen to Reduce Alcohol Use in Veterans With HCVConditions: Hepatitis C - Alcohol Use Disorders
2 Locations available
- Cell Bound Complement Activation Proteins as Markers of Liver InjuryConditions: Hepatitis C
1 Location available
- A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-InfectionConditions: Chronic Hepatitis B Virus, Pediatric
13 Locations available
- A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus InfectioConditions: Chronic Hepatitis C Virus Infection
12 Locations available
- Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis CConditions: HCV Infection - Liver Transplantation
8 Locations available
- Computer-Assisted Tailored Cue-card Health [CATCH] StudyConditions: Human Immunodeficiency Virus - STDs - Hepatitis, Viral, Human
1 Location available
- The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)Conditions: Non-alcoholic Fatty Liver Disease - Nonalcoholic Steatohepatitis (NASH)
10 Locations available
- Vitamin D Deficiency in Subjects With Chronic Hepatitis C Compared to Healthy VolunteersConditions: Chronic Hepatitis C
1 Location available
- A Study on The Combination of RO5024048 And Ritonavir-Boosted Danoprevir With And Without Copegus (Ribavirin) in Interferon-Naïve Patients With ChroniConditions: Hepatitis C, Chronic
11 Locations available
- TMC435HPC3007 - Phase III Trial of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous TherapyConditions: Hepatitis C
10 Locations available
- Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCVConditions: Chronic Hepatitis C
1 Location available
- Evaluation of Patients With Liver DiseaseConditions: Biliary Liver Cirrhosis, - Hemochromatosis - Hepatitis - Hepatolenticular Degeneration - Liver Disease
1 Location available
- Immune Response to Hepatitis C VirusConditions: Hepatitis C
1 Location available
- Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-InfectionConditions: Thrombocytopenia - Hepatitis C - HIV Infections
1 Location available
- Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C PatientsConditions: Alcohol Dependence - Chronic Hepatitis C
2 Locations available
- Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic SteatohepatitisConditions: Non-cirrhotic Non-alcoholic Steatohepatitis
5 Locations available
- Placebo-Controlled, Dose-Escalation Study of the Safety of IMO-2125 in Hepatitis C-Infected PatientsConditions: Hepatitis C
6 Locations available
- Study of Maternal Hepatitis C Infection and Influenza Vaccination in PregnancyConditions: Hepatitis C
1 Location available
- Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIVConditions: HIV Infections - Hepatitis C Virus
2 Locations available
- TMC435-TiDP16-C113: A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of TMC435Conditions: Hepatitis C Virus
3 Locations available
- Safety, Tolerability and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in HCV Positive SubjectsConditions: Hepatitis C
9 Locations available
- Ph IIA Study (SOC +/- NS5B)Conditions: Hepatitis C Virus
10 Locations available
- Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein ProfilingConditions: Hepatitis C
1 Location available
- Hepatitis B Research Network Adult Cohort StudyConditions: Hepatitis B
20 Locations available
- Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Conditions: Chronic Hepatitis B
11 Locations available
- Safety and Efficacy of ANA598 Administered With Pegylated Interferon and Ribavirin in Genotype-1 Patients With Chronic HCV InfectionConditions: Hepatitis C
30 Locations available
- Efficacy and Safety of BI201335 in Combination With Pegylated Interferon Alpha and Ribavirin in Treatment Naive Genotype 1 Hepatitis C Infected PatienConditions: Hepatitis C
30 Locations available
- HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis BConditions: Hepatitis B
11 Locations available
- Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected SubjectsConditions: Hepatitis C Virus (HCV) - Chronic Hepatitis C
4 Locations available
- Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have PreviouslConditions: Chronic Hepatitis C
10 Locations available
- Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype Conditions: Hepatitis C, Chronic
2 Locations available
- Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver TransplantConditions: Hepatitis C - Hepatitis C, Chronic
5 Locations available
- Effects of HIV and Hepatitis C Virus on the BrainConditions: HIV Infections - Hepatitis C
1 Location available
- HIV and Hepatitis Care Coordination in Methadone TreatmentConditions: Hepatitis, Viral, Human - HIV Infections
2 Locations available
- Prevention of Depression in HIV/HCV co-Infected Substance Abuse PatientsConditions: Hepatitis C - Depressive Disorder, Major - Depressive Disorder - Depression - HIV Infections
1 Location available
- Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV PatientsConditions: Hepatitis C
1 Location available
- High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1Conditions: Chronic Hepatitis C
1 Location available
- Efficacy of Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant Chronic Hepatitis C (CHC) Genotype 1 (GT 1) SubjectsConditions: Chronic Hepatitis C
1 Location available
- Brief Intervention for Drug Misuse in the Emergency DepartmentConditions: Substance Abuse Detection - Acquired Immunodeficiency Syndrome - Hepatitis B - Hepatitis C - Brief Intervention - HIV Infections
1 Location available
- Study the Relationship Between Obesity and Hepatitis C ReplicationConditions: Hepatitis C
1 Location available
- Epidemiological Study in Children and Adolescents With Chronic Hepatitis BConditions: Liver Diseases - Hepatitis, Chronic - Hepatitis, Viral, Human - Hepatitis - Virus Diseases - Digestive System Diseases - Hepatitis B, Chronic - Hepatitis B - DNA Virus Infections
3 Locations available
- An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic HepatConditions: Hepatitis C, Chronic
3 Locations available
- TMC435-TiDP16-C208 - Phase III Trial of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected PatientsConditions: Hepatitis C
21 Locations available
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RConditions: Chronic Hepatitis C, Hepatitis C, Hepatitis C Virus (HCV)
1 Location available
- Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)Conditions: Hepatitis D
2 Locations available
- A Open-label Study to Evaluate the Relative Bioavailability of IDX184 and Food Effect in Healthy Male SubjectsConditions: Hepatitis C
1 Location available
- Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver DiseaseConditions: Cirrhosis - End Stage Liver Disease - Hepatitis C
1 Location available
- Racial Difference in HCV/Host InteractionsConditions: Hepatitis C
3 Locations available
- Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1Conditions: Depressive Disorder, Major - Hepatitis C
1 Location available
- HIV-HCV Coinfection: Impact of Immune DysfunctionConditions: HIV Infections - Hepatitis
1 Location available
- Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)Conditions: Nonalcoholic Steatohepatitis - Nonalcoholic Fatty Liver Disease
1 Location available
- Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant PatientsConditions: Hepatitis B - Liver Transplantation
7 Locations available
- Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocelluar CarcinomaConditions: Liver Cancer - Hepatitis B - Hepatitis C - Hepatobiliary Cancers Liver - Hepatobiliary Cancers
1 Location available
- Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of TreatmentConditions: Nonalcoholic Steatohepatitis
1 Location available
- Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis CConditions: Chronic Hepatitis C - Oxidative Stress
1 Location available
- Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus InfectionConditions: Hepatitis C Virus
1 Location available
- Efficacy and Safety of DEB025 Combined With Peg-IFN Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Relapsers and Non-respondersConditions: Hepatitis C Chronic
8 Locations available
- The Effect of Human Immunodeficiency Virus (HIV) Tat Protein on Hepatitis C Virus (HCV) Replication in an In-vitro Model SystemConditions: Human Immunodeficiency Virus (HIV) - Hepatitis C, Chronic
1 Location available
- Efficacy and Safety of DEB025 Alone or Combined With Either Ribavirin or Peg-IFN α2a in Chronic Hepatitis C Genotype 2 and 3 naïve PatientsConditions: Hepatitis C - Chronic Pain
1 Location available
- Hepatitis B Research Network Pediatric Cohort Study (HBRN)Conditions: Hepatitis B
5 Locations available
- Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV MedsConditions: HIV Infection - Hepatitis C Virus Infection
1 Location available
- Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic SteatohepatitisConditions: Non Alcoholic Fatty Liver Diseases (NAFLD)
1 Location available
- PSI-7977 With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6Conditions: Hepatitis C, Chronic
29 Locations available
- The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected PatientsConditions: HIV - Hepatitis C - HIV and Hepatitis C Coinfection
1 Location available
- GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C VirusConditions: Hepatitis C, Chronic
1 Location available
|
No comments:
Post a Comment